No Long-Term Advantage Seen for Off-Pump Versus On-Pump CABG

THURSDAY, March 10, 2022 (HealthDay News) -- Coronary artery bypass grafting (CABG) outcomes are similar at 10 years for veterans undergoing "on-pump" or "off-pump" procedures, according to a study published online Feb. 16 in JAMA Surgery.
Jacquelyn A. Quin, M.D., from the Veterans Affairs Boston Healthcare System in West Roxbury, Massachusetts, and colleagues evaluated the 10-year outcomes and costs of off-pump versus on-pump CABG. The analysis included 2,203 veterans randomly assigned to the off-pump group (1,104 patients) or the on-pump group (1,099 patients).
The researchers found that the 10-year death rates were 34.2 percent for the off-pump group and 31.1 percent for the on-pump group (relative risk, 1.05; 95 percent confidence interval, 0.99 to 1.11; P = 0.12). For the off-pump group, the median time to the composite end point (all-cause death or repeated revascularization) was 4.6 years, which was approximately 4.3 months shorter than that for the on-pump group (5.0 years). There were no significant 10-year treatment-related differences for any other primary or secondary end points.
"For veterans, in the absence of contraindications, the traditional on-pump CABG technique should not be supplanted by an off-pump CABG approach," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
Psychological Interventions May Reduce Depression in Dementia Patients
WEDNESDAY, May 4, 2022 (HealthDay News) -- Talk therapy may alleviate depression...
Use of Proton Beam Therapy for Newly Diagnosed Cancer on the Rise
FRIDAY, May 6, 2022 (HealthDay News) -- The number of U.S. patients receiving...
Un programa virtual podría hacer que la conducción sea más segura para los adolescentes con TDAH
JUEVES, 1 de diciembre de 2022 (HealthDay News) -- Un simulador podría hacer que...
Persisten los mitos y la ignorancia respecto al cáncer de pulmón, según una encuesta
LUNES, 1 de agosto de 2022 (HealthDay News) -- El cáncer de pulmón es la...